Fluorescence Spectroscopic Study of Hypericin-photosensitized Oxidation of Low-density Lipoproteins

Abstract By means of UV-VIS absorption and fluorescence spectroscopy, we demonstrate that the photosensitizer hypericin (Hyp) interacts nonspecifically with low-density lipoproteins (LDL), most probably with the lipid fraction of LDL. The molar ratio of monomeric Hyp binding to nonoxidized LDL and mildly oxidized LDL is 30:1. Increasing the Hyp concentration further leads to the formation of Hyp aggregates inside the LDL molecule. We also demonstrate that photoactivated Hyp oxidizes LDL in a light dose and excitation wavelength dependent manner. The level of oxidation of LDL depends on the amount of Hyp inside the LDL molecule. The maximum of the photosensitized oxidation of the LDL by Hyp is achieved for a 30:1 molar ratio, which corresponds to the maximum concentration of monomeric form of Hyp in LDL.

[1]  T. Theodossiou,et al.  Evidence for Intracellular Aggregation of Hypericin and the Impact on its Photocytotoxicity in PAM 212 Murine Keratinocytes¶ , 2004, Photochemistry and photobiology.

[2]  P. Morlière,et al.  Dynamics of interactions of photosensitizers with lipoproteins and membrane-models: correlation with cellular incorporation and subcellular distribution. , 2004, Biochemical pharmacology.

[3]  J. Laranjinha,et al.  Simultaneous Production of Superoxide Radical and Singlet Oxygen by Sulphonated Chloroaluminum Phthalocyanine Incorporated in Human Low-density Lipoproteins: Implications for Photodynamic Therapy¶ , 2004, Photochemistry and photobiology.

[4]  Badrinath R Konety,et al.  Fluorescence cystoscopy and bladder surveillance , 2004, Current opinion in urology.

[5]  P. D. de Witte,et al.  Liposomes for photodynamic therapy. , 2004, Advanced drug delivery reviews.

[6]  J. V. van Lier,et al.  Targeted photodynamic therapy via receptor mediated delivery systems. , 2004, Advanced drug delivery reviews.

[7]  P. Tan,et al.  Novel photodynamic diagnosis of bladder cancer: ex vivo fluorescence cytology using hypericin. , 2003, International journal of oncology.

[8]  T. Roskams,et al.  Whole bladder wall photodynamic therapy of transitional cell carcinoma rat bladder tumors using intravesically administered hypericin , 2003, International journal of cancer.

[9]  M. Olivo,et al.  Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer. , 2003, International journal of oncology.

[10]  H. Falk,et al.  A Unique Photoreaction of Hypericinate Bound to Human Serum Albumin, Lipids, or Vesicles , 2003 .

[11]  P. Tan,et al.  Macro-microscopic fluorescence of human bladder cancer using hypericin fluorescence cystoscopy and laser confocal microscopy. , 2003, International journal of oncology.

[12]  R. K. Chowdhary,et al.  Correlation of photosensitizer delivery to lipoproteins and efficacy in tumor and arthritis mouse models; comparison of lipid-based and Pluronic P123 formulations. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[13]  T. Roskams,et al.  Microscopic quantification of hypercin fluorescence in an orthotopic rat bladder tumor model after intravesical instillation. , 2003, International journal of oncology.

[14]  A. Nègre-Salvayre,et al.  Oxidized low-density lipoprotein-induced apoptosis. , 2002, Biochimica et biophysica acta.

[15]  P. Morlière,et al.  Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins. , 2002, Biophysical journal.

[16]  François Guillemin,et al.  Fluorescence detection of bladder cancer: a review. , 2002, European urology.

[17]  Anatoly B Uzdensky,et al.  Photobleaching of Hypericin Bound to Human Serum Albumin, Cultured Adenocarcinoma Cells and Nude Mice Skin¶ , 2002, Photochemistry and photobiology.

[18]  Z. Malik,et al.  The correlation between hydrophilicity of hypericins and helianthrone: internalization mechanisms, subcellular distribution and photodynamic action in colon carcinoma cells , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[19]  T. Roskams,et al.  Hypericin‐based fluorescence diagnosis of bladder carcinoma , 2002, BJU international.

[20]  P. Agostinis,et al.  Hypericin in cancer treatment: more light on the way. , 2002, The international journal of biochemistry & cell biology.

[21]  R. Gurny,et al.  State of the art in the delivery of photosensitizers for photodynamic therapy. , 2002, Journal of photochemistry and photobiology. B, Biology.

[22]  N. Schmeller,et al.  New aspect of photodynamic diagnosis of bladder tumors: fluorescence cytology. , 2002, Urology.

[23]  P. Miškovský,et al.  Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules. , 2002, Current Drug Targets.

[24]  L. Polo,et al.  Low-density lipoprotein receptors in the uptake of tumour photosensitizers by human and rat transformed fibroblasts. , 2002, The international journal of biochemistry & cell biology.

[25]  J. Segrest,et al.  Structure of apolipoprotein B-100 in low density lipoproteins. , 2001, Journal of lipid research.

[26]  S. Sánchez‐Cortés,et al.  Interaction of Hypericin with Serum Albumins: Surface-enhanced Raman Spectroscopy, Resonance Raman Spectroscopy and Molecular Modeling Study¶ , 2001, Photochemistry and photobiology.

[27]  G. Lavie,et al.  ANTI-cancer Activities of Hypericin in the Dark¶ , 2001, Photochemistry and photobiology.

[28]  Yan Xu,et al.  Efficacy of antitumoral photodynamic therapy with hypericin: Relationship between biodistribution and photodynamic effects in the RIF‐1 mouse tumor model , 2001, International journal of cancer.

[29]  Thomas J. Dougherty,et al.  Basic principles of photodynamic therapy , 2001 .

[30]  Michal Afri,et al.  Solvatochromic Effects in the Electronic Absorption and Nuclear Magnetic Resonance Spectra of Hypericin in Organic Solvents and in Lipid Bilayers¶ , 2001, Photochemistry and photobiology.

[31]  P. Fedoročko,et al.  Photodynamic therapy of murine fibrosarcoma with topical and systemic administration of hypericin. , 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[32]  J. Moan,et al.  Intracellular Localisation of Hypericin in Human Glioblastoma and Carcinoma Cell Lines , 2001, Lasers in Medical Science.

[33]  J. Petrich.  Excited State Intramolecular Hydrogen Atom Transfer in Nearly Symmetrical Perylene Quinones: Hypericin, Hypocrellin, and Their Analogues , 2000 .

[34]  L. Baert,et al.  Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. , 2000, The Journal of urology.

[35]  J. Petrich.  Excited-state intramolecular H-atom transfer in nearly symmetrical perylene quinones: Hypericin, hypocrellin, and their analogues , 2000 .

[36]  Falk,et al.  From the Photosensitizer Hypericin to the Photoreceptor Stentorin- The Chemistry of Phenanthroperylene Quinones. , 1999, Angewandte Chemie.

[37]  J. Petrich,et al.  Photophysics of Hypericin and Hypocrellin A in Complex with Subcellular Components: Interactions with Human Serum Albumin , 1999, Photochemistry and photobiology.

[38]  A. Moor,et al.  Oxidized low-density lipoprotein as a delivery system for photosensitizers: implications for photodynamic therapy of atherosclerosis. , 1999, The Journal of pharmacology and experimental therapeutics.

[39]  B. Ehrenberg,et al.  Kinetics and Yield of Singlet Oxygen Photosensitized by Hypericin in Organic and Biological Media , 1998, Photochemistry and photobiology.

[40]  S. Sánchez‐Cortés,et al.  Antiretrovirally Active Drug Hypericin Binds the IIA Subdomain of Human Serum Albumin: Resonance Raman and Surface-Enhanced Raman Spectroscopy Study , 1998 .

[41]  A. Losi.  Fluorescence and Time‐Resolved Photoacoustics of Hypericin Inserted in Liposomes: Dependence on Pigment Concentration and Bilayer Phase , 1997 .

[42]  R. Cubeddu,et al.  Artificial models of biological photoreceptors: effect of quenchers on the fluorescence properties of hypericin embedded in liposomes , 1997 .

[43]  E. Reddi,et al.  Role of delivery vehicles for photosensitizers in the photodynamic therapy of tumours. , 1997, Journal of photochemistry and photobiology. B, Biology.

[44]  G. Jori,et al.  Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. , 1996, Journal of photochemistry and photobiology. B, Biology.

[45]  C. Hadjur,et al.  Photodynamic Effects of Hypericin on Lipid Peroxidation and Antioxidant Status in Melanoma Cells , 1996, Photochemistry and photobiology.

[46]  P. Jardon,et al.  Homo-association de l'hypéricine dans l'eau et conséquences sur ses propriétés photodynamiques , 1996 .

[47]  T. Utsumi,et al.  Effect of the antiretroviral agent hypericin on rat liver mitochondria. , 1995, Biochemical pharmacology.

[48]  C. Hadjur,et al.  Quantitative analysis of superoxide anion radicals photosensitized by hypericin in a model membrane using the cytochrome c reduction method , 1995 .

[49]  R. Cubeddu,et al.  SPECTROSCOPIC AND PHOTOACOUSTIC STUDIES OF HYPERICIN EMBEDDED IN LIPOSOMES AS A PHOTORECEPTOR MODEL* , 1995, Photochemistry and photobiology.

[50]  Z. Diwu.  NOVEL THERAPEUTIC AND DIAGNOSTIC APPLICATIONS OF HYPOCRELLINS AND HYPERICINS , 1995, Photochemistry and photobiology.

[51]  D. Meruelo,et al.  Hypericin as an inactivator of infectious viruses in blood components , 1995, Transfusion.

[52]  C. Hadjur,et al.  Photodynamically induced cytotoxicity of hypericin dye on human fibroblast cell line MRC5. , 1995, Journal of photochemistry and photobiology. B, Biology.

[53]  C. Hadjur,et al.  Photosensitization by hypericin: Electron spin resonance (ESR) evidence for the formation of singlet oxygen and superoxide anion radicals in an in vitro model☆ , 1994 .

[54]  Michael R Hamblin,et al.  Photosensitizer targeting in photodynamic therapy. I. Conjugates of haematoporphyrin with albumin and transferrin. , 1994, Journal of photochemistry and photobiology. B, Biology.

[55]  Raymond A. Firestone.  Low-Density Lipoprotein as a Vehicle for Targeting Antitumor Compounds to Cancer Cells , 1994 .

[56]  H. Falk,et al.  On the homo- and heteroassociation of hypericin , 1994 .

[57]  R. Firestone,et al.  Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. , 1994, Bioconjugate chemistry.

[58]  E. Reddi,et al.  The role of lipoproteins in the delivery of tumour-targeting photosensitizers. , 1993, The International journal of biochemistry.

[59]  M. Korbelik,et al.  CELLULAR DELIVERY AND RETENTION OF PHOTOFRIN: III. ROLE OF PLASMA PROTEINS IN PHOTOSENSITIZER CLEARANCE FROM CELLS , 1993, Photochemistry and photobiology.

[60]  J. Lown,,et al.  Photosensitization with anticancer agents. 17. EPR studies of photodynamic action of hypericin: formation of semiquinone radical and activated oxygen species on illumination. , 1993, Free radical biology & medicine.

[61]  P. Jardon,et al.  Autoextinction de la fluorescence et de l'absorption triplet-triplet de l'hypericine dans des liposomes de dipalmitoylphosphatidylcholine : application à l'étude de la diffusion intervésiculaire de l'hypericine , 1993 .

[62]  O. Larsson,et al.  Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo. , 1992, Cancer research.

[63]  A. Nègre-Salvayre,et al.  WAVELENGTH DEPENDENCE OF PHOTOINDUCED PEROXIDATION AND CYTOTOXICITY OF HUMAN LOW DENSITY LIPOPROTEINS , 1992, Photochemistry and photobiology.

[64]  L. Grossweiner,et al.  Photosensitization of aqueous model systems by hypericin. , 1992, Biochimica et biophysica acta.

[65]  G. C. Miller,et al.  PHOTOACTIVATION OF HYPERICIN GENERATES SINGLET OXYGEN IN MITOCHONDRIA AND INHIBITS SUCCINOXIDASE , 1992, Photochemistry and photobiology.

[66]  D. Meruelo,et al.  A method for the quantitation of hypericin, an antiviral agent, in biological fluids by high-performance liquid chromatography. , 1991, Analytical biochemistry.

[67]  P. Morlière,et al.  The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours. , 1991, Journal of photochemistry and photobiology. B, Biology.

[68]  P. Morlière,et al.  MODIFICATION OF ε‐AMINO GROUP OF LYSINES, CHOLESTEROL OXIDATION AND OXIDIZED LIPID‐APOPROTEIN CROSS‐LINK FORMATION BY PORPHYRIN‐PHOTOSENSITIZED OXIDATION OF HUMAN LOW DENSITY LIPOPROTEINS , 1988 .

[69]  K. Yagi.  Lipid peroxides and human diseases. , 1987, Chemistry and physics of lipids.

[70]  L. Dubertret,et al.  PHOTOSENSITIZATION BY PORPHYRINS DELIVERED TO L CELL FIBROBLASTS BY HUMAN SERUM LOW DENSITY LIPOPROTEINS. A MICROSPECTROFLUOROMETRIC STUDY , 1987, Photochemistry and photobiology.

[71]  L. Dubertret,et al.  INTERACTION OF HUMAN SERUM LOW DENSITY LIPOPROTEINS WITH PORPHYRINS: A SPECTROSCOPIC AND PHOTOCHEMICAL STUDY , 1984, Photochemistry and photobiology.

[72]  M. Brown,et al.  Receptor-mediated control of cholesterol metabolism. , 1976, Science.